Crossmark Global Holdings Inc. Has $381,000 Stock Holdings in Albemarle Co. (NYSE:ALB)

Crossmark Global Holdings Inc. trimmed its holdings in shares of Albemarle Co. (NYSE:ALB) by 20.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,020 shares of the specialty chemicals company’s stock after selling 1,022 shares during the period. Crossmark Global Holdings Inc.’s holdings in Albemarle were worth $381,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Jane Street Group LLC increased its holdings in shares of Albemarle by 176.6% in the 1st quarter. Jane Street Group LLC now owns 1,588,986 shares of the specialty chemicals company’s stock valued at $209,333,000 after purchasing an additional 3,662,117 shares during the period. Pathway Financial Advisers LLC increased its stake in Albemarle by 9,108.7% in the 3rd quarter. Pathway Financial Advisers LLC now owns 574,805 shares of the specialty chemicals company’s stock valued at $54,440,000 after buying an additional 568,563 shares during the period. Capital World Investors purchased a new stake in Albemarle in the 1st quarter worth approximately $49,007,000. PGGM Investments grew its holdings in shares of Albemarle by 261.6% during the 1st quarter. PGGM Investments now owns 413,492 shares of the specialty chemicals company’s stock valued at $54,473,000 after acquiring an additional 299,148 shares in the last quarter. Finally, HB Wealth Management LLC increased its stake in shares of Albemarle by 115.7% in the second quarter. HB Wealth Management LLC now owns 542,200 shares of the specialty chemicals company’s stock worth $51,791,000 after acquiring an additional 290,862 shares during the last quarter. 92.87% of the stock is owned by hedge funds and other institutional investors.

Albemarle Stock Up 1.4 %

Shares of ALB opened at $103.53 on Monday. The company has a quick ratio of 1.58, a current ratio of 2.44 and a debt-to-equity ratio of 0.43. The company has a 50-day moving average price of $95.52 and a two-hundred day moving average price of $99.79. The stock has a market cap of $12.17 billion, a price-to-earnings ratio of -6.18 and a beta of 1.55. Albemarle Co. has a 12 month low of $71.97 and a 12 month high of $153.54.

Albemarle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, December 13th will be given a dividend of $0.405 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $1.62 annualized dividend and a yield of 1.56%. Albemarle’s dividend payout ratio (DPR) is -9.67%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Royal Bank of Canada lifted their price target on Albemarle from $108.00 to $133.00 and gave the company an “outperform” rating in a report on Tuesday, November 12th. Evercore ISI decreased their target price on shares of Albemarle from $190.00 to $170.00 and set an “outperform” rating for the company in a research report on Wednesday, August 28th. Wells Fargo & Company raised their price target on shares of Albemarle from $100.00 to $110.00 and gave the company an “equal weight” rating in a report on Tuesday, October 8th. JPMorgan Chase & Co. decreased their price objective on shares of Albemarle from $115.00 to $78.00 and set a “neutral” rating for the company in a report on Monday, August 19th. Finally, KeyCorp cut their target price on Albemarle from $132.00 to $127.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $114.47.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.